Skip to main content
VCbacked
Log inGet Started

Paradigm Biopharmaceuticals

Melbourne, Australia

Paradigm is a global biopharmaceutical company driven to discover to improve patients’ health and quality of life

$10.1M raised
Apr 2026
Post-IPO Equity
BiotechnologyHealth CareMedical

Top Investors

Obsidian Global Partners

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Paradigm Biopharmaceuticals

How much funding has Paradigm Biopharmaceuticals raised?
Paradigm Biopharmaceuticals has raised $10.1M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Who are Paradigm Biopharmaceuticals's investors?
Paradigm Biopharmaceuticals's investors include Obsidian Global Partners.
Where is Paradigm Biopharmaceuticals headquartered?
Paradigm Biopharmaceuticals is headquartered in Melbourne, Australia.
What does Paradigm Biopharmaceuticals do?
Paradigm is a global biopharmaceutical company driven to discover to improve patients’ health and quality of life
What stage is Paradigm Biopharmaceuticals at?
Paradigm Biopharmaceuticals is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Paradigm Biopharmaceuticals — Funding & Investors." VCBacked, April 27, 2026, https://www.vcbacked.co/company/paradigm-biopharmaceuticals. Accessed July 3, 2026.
APA
VCBacked. (2026). Paradigm Biopharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/paradigm-biopharmaceuticals
Wikipedia (cite web)
{{cite web |title=Paradigm Biopharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/paradigm-biopharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K